Skip to content

The CDMO Partner You Need.

Accelerating Complex Modalities from Development to Commercial

  • Purpose‑built technology platforms to support your complex modalities
  • True end‑to‑end CDMO services that secure your supply chain
  • Speed to market, with efficient scale‑up from clinical to commercialization
  • Quality‑driven manufacturing with deep regulatory and compliance expertise

Seamless Supply with True End-to-End Support

Why Choose CordenPharma?

As pharma innovators, your CDMO partner must bring the expertise, scale, and regulatory strength to support your programs at every stage. With decades of experience across six technology platforms, a global network expansion spanning three continents, and hundreds of years of combined facility expertise, we deliver true end-to-end services across the complete drug lifecycle, from drug substance to drug product. Our integrated capabilities and expanded capacity enable consistent execution, supporting development, clinical supply, and large-scale commercial manufacturing with confidence.

960

€ Million Net Sales

(in 2025)

11

cGMP Facilities Across Europe & North America

~

100

Commercial Products Supported

>

250

Active Customers

10

Health Authorities Audits

(in 2025)

80

Customer Audits

(in 2025)

What You Need

APIs

Find out more

We understand what is at stake in your API program and bring decades of experience in development and manufacturing to ensure a reliable, high-quality drug substance supply that keeps your project progressing with confidence.

Our API development & manufacturing capabilities include:

Drug Products

Find out more

Our broad spectrum of drug product capabilities spans from clinical development through commercialization across a wide range of dosage forms, including Oral Solid Dosage (OSD), Aseptic Fill and Finish sterile injectables, and Oral Peptide Delivery, covering multiple modalities, including highly potent compounds. With advanced packaging, labeling, and serialization capabilities, we deliver reliable, high-quality drug product supply to support your program at every stage. 

Our Drug Product development & manufacturing capabilities include:

Lipid Excipients & Nanomedicines

Find out more

We are a global CDMO leader in pioneering specialized lipid-based products, supporting the development and manufacturing of nanomedicines with expertise in synthetic lipid process development, LNP formulation, scale-up, and large-scale manufacturing. Our high-quality lipid excipient building blocks, LNP starter kits, and cutting-edge technologies support your supply of lipid-based medicines, no matter the scale or phase of development. 

Our Lipid Excipient and Nanomedicine capabilities include:

True End-to-End Supply

Managing multiple CDMOs across development stages and technologies increases coordination effort, risk, and timelines. CordenPharma integrates development and manufacturing of complex modalities across APIs, Drug Products and Packaging at all scales, coordinated through a global delivery and project management model.

What this means for you: 

  • Fewer handovers between suppliers and project phases
  • Clear accountability across development and manufacturing activities
  • Better visibility and control from early development through commercial supply
Learn more

 

Ready to start your CDMO project?

Want to find out more?